Anti-Vascular Endothelial Growth Factor Intravitreal Therapy and Macular Ganglion Cell Layer Thickness in Patients with Neovascular Age-Related Macular Degeneration. [electronic resource]
Producer: 20201016Description: 1000-1005 p. digitalISSN:- 1460-2202
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Choroidal Neovascularization -- drug therapy
- Female
- Follow-Up Studies
- Humans
- Intraocular Pressure -- physiology
- Intravitreal Injections
- Male
- Nerve Fibers -- pathology
- Ranibizumab -- therapeutic use
- Receptors, Vascular Endothelial Growth Factor -- therapeutic use
- Recombinant Fusion Proteins -- therapeutic use
- Retinal Ganglion Cells -- pathology
- Retrospective Studies
- Tomography, Optical Coherence
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
- Wet Macular Degeneration -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.